Q3-2018 Ophthalmology Update

Investment activity in the third quarter was highlighted by two landmark private equity recapitalizations in the Tri-State area with SightMD and NJRetina each aligning with capital partners to execute on their respective growth initiatives. The willingness of private equity firms to invest in geographies with existing platforms indicates that the ophthalmology sector remains highly fragmented and attractive for investment. In the case of NJRetina, their recapitalization marks the first time a retina practice will serve as a platform investment for a private equity firm entering the subsector and represents the 20th private equity firm to invest into ophthalmology since 2014. With strategic consolidators keen on growing through acquisitions, Provident expects transaction volume, and in particular add-on acquisition volume, to remain at elevated levels for the foreseeable future.

To print and download the full Ophthalmology Update report, please click below…


Sources: SEC Filings; Company Press Releases, and Reports; IBISWorld; Capital IQ; PHP Estimates and Research. This document has been compiled with publicly available information. Provident Healthcare Partners, LLC makes no guarantee of its accuracy or completeness. No data or statement should be construed to be a recommendation for the purchase, sale, or retention of any security.
  • “While the decision to sell our business was a difficult one, Provident vigilantly represented and protected our best interests throughout the transaction.  Provident was the right choice for Cascade and I would recommend their services to anyone.”

  • “A lot of investment bankers were interviewed, Provident was chosen. Provident delivered. My clients could not be happier.”

  • “Provident’s depth of experience and practical business savvy was demonstrated in their ability to cut through what sometimes looked like impasse.”

  • “After working with Provident on several transactions, it is evident that their extensive industry knowledge and deal expertise prove to be invaluable to their clients.”

  • “We would not have been successful navigating the process without Provident’s hard work and active participation. They exceeded our expectations and we would highly recommend them to any health care company seeking a knowledgeable and engaged investment banking firm.”

  • ”I have a tremendous amount of appreciation and gratitude to the Provident team for their hard work and diligence throughout this process. Each and every member of the Provident team is excellent at their jobs and it has been a pleasure working with such a professional team. Provident has provided outstanding guidance and counsel, and this deal could never have gotten done without Provident’s leadership.”

  • “Provident listened to our story, confirmed that our business was valuable and made us feel like this was the only transaction important to them.”